International nonproprietary name: difference between revisions
Diff·revision 18 → 19·07:43, 18 Aug 2025
Difference between revision 18 and revision 19 of International nonproprietary name. 3 lines changed; the page grew by 356 bytes.
| Revision 18 — 11:19, 28 Jul 2025 ExenatideEzra (talk) state which salt form the mass in the infobox refers to 4,000 bytes ±0 | Revision 19 — 07:43, 18 Aug 2025 TirzTaxonomist (talk) add see also to the amylin analogue 4,356 bytes +356 | ||
|---|---|---|---|
| 40 | For material sold outside licensed supply, a name on a label is an assertion like any other field. A vial labelled with an INN has been labelled; whether its contents correspond is an identity question answered by [[Mass spectrometry|mass determination]], not by the label.{{r|usp1503,aebersold2003}} See [[Counterfeit peptide]]. | 40 | For material sold outside licensed supply, a name on a label is an assertion like any other field. A vial labelled with an INN has been labelled; whether its contents correspond is an identity question answered by [[Mass spectrometry|mass determination]], not by the label.{{r|usp1503,aebersold2003}} See [[Counterfeit peptide]]. |
| 41 | 41 | ||
| + | 42 | Names not on the INN list — bare development codes, laboratory abbreviations, or invented names — do not identify a substance uniquely and may be used for different compounds by different suppliers.{{r|reports}} | |
| + | 43 | ||
| 42 | == References == | 44 | == References == |
| 43 | {{reflist}} | 45 | {{reflist}} |
| 44 | <ref name="who_inn">World Health Organization, ''Guidance on the Use of International Nonproprietary Names (INNs) for Pharmaceutical Substances'' and the published INN stem list.</ref> | 46 | <ref name="who_inn">World Health Organization, ''Guidance on the Use of International Nonproprietary Names (INNs) for Pharmaceutical Substances'' and the published INN stem list.</ref> |
| 45 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> | 47 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> |
| + | 48 | <ref name="reports">PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see [[Project:Sourcing_guidelines]]).</ref> | |
| 46 | <ref name="aebersold2003">Aebersold R, Mann M. "Mass spectrometry-based proteomics." ''Nature'' 422(6928):198–207 (2003). PMID 12634793.</ref> | 49 | <ref name="aebersold2003">Aebersold R, Mann M. "Mass spectrometry-based proteomics." ''Nature'' 422(6928):198–207 (2003). PMID 12634793.</ref> |
| 47 | 50 |